SCHEMBL4853937

SCHEMBL4853937

CCOc1ccccc1C=CC(=O)c1cc(-c2cc(C)cc(C)c2)ccc1OCCN(C)C

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.49
SMN1; SMN2 Q16637 3/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
ATM Q13315 1/20 0.46
SYK P43405 2/20 0.42
CAPN1 P07384 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
ESR1 P03372 1/20 0.41
XDH P47989 1/20 0.40
SLC6A9 P48067 2/20 0.40
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HRH1 P35367 1/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4845755 1.00 AR (0.49) ARSMN1; SMN2LMNAMAPTATM
SCHEMBL4849808 0.96 SYK (0.45) ARSMN1; SMN2LMNAMAPTATM
SCHEMBL4852245 0.96 SYK (0.45) ARSMN1; SMN2LMNAMAPTATM
SCHEMBL4855081 0.93 AR (0.46) ARSMN1; SMN2LMNAMAPTATM
SCHEMBL4848280 0.93 AR (0.46) ARSMN1; SMN2LMNAMAPTATM
SCHEMBL4853093 0.93 KDM4E (0.47) ARSMN1; SMN2SYKSLC6A9KDM4E
SCHEMBL4849704 0.93 KDM4E (0.47) ARSMN1; SMN2SYKSLC6A9KDM4E
SCHEMBL4853942 0.92 AR (0.45) ARSMN1; SMN2LMNAMAPTATM
SCHEMBL4855031 0.90 KDM4E (0.48) ARSMN1; SMN2MAPTSYKSLC6A9
SCHEMBL4847178 0.90 KDM4E (0.48) ARSMN1; SMN2MAPTSYKSLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed